bioMérieux (OTCMKTS:BMXMF) Stock Crosses Below 50 Day Moving Average – Time to Sell?

Shares of bioMérieux S.A. (OTCMKTS:BMXMF) passed below its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $113.87 and traded as low as $112.89. bioMérieux shares last traded at $112.89, with a volume of 9,557 shares changing hands.

Analyst Upgrades and Downgrades

Separately, UBS Group upgraded bioMérieux to a “strong-buy” rating in a research report on Thursday, August 22nd.

bioMérieux Stock Down 2.5 %

The stock has a fifty day simple moving average of $113.87 and a two-hundred day simple moving average of $106.86. The company has a current ratio of 2.03, a quick ratio of 1.19 and a debt-to-equity ratio of 0.09.

bioMérieux Company Profile

bioMérieux SA develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries.